Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/4/2019
SIETES contiene 92718 citas

 
 
 1 a 20 de 812 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLOS Medicine 2019:13 de marzo. [Ref.ID 103076]
2. Cita con resumen
Taylor P. GSK, J&J say monthly injection keeps HIV controlled. PMLiVE 2019:8 de marzo. [Ref.ID 103051]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW. Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med 2018;178:julio. [Ref.ID 102882]
4.Enlace a cita original Cita con resumen
Howard R, Fry B, Gunaseelan V, Lee J, Waljee J, Brummett C, Campbell Jr D, Seese E, Englesbe M, Vu J. Association of opioid prescribing with opioid consumption after surgery in Michigan. JAMA Surgery 2018:7 de noviembre. [Ref.ID 102846]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K, on behalf of the show SPYRAL HTN-ON MED Trial Investigators. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 2018;391:9 de junio. [Ref.ID 102692]
7.Enlace a cita originalTiene citas relacionadas Cita con resumen
Blankestijn PJ, Bots ML. Renal denervation in uncontrolled hypertension: the story continues to unfold. Lancet 2018;391:9 de junio. [Ref.ID 102690]
8.Enlace a cita original Cita con resumen
Gellad WF, Thorpe CT, Steiner JF, Voils CI. The myths of medication adherence. Pharmacoepidemiol Drug Saf 2017;27:diciembre. [Ref.ID 102186]
9. Cita con resumen
Anónimo. FDA approves first digital pill. DIA Daily 2017:1. [Ref.ID 102142]
10. Cita con resumen
Aznar-Lou I, Fernández A, Gil-Gibau M, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-María MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol MA, Jové AM, Rubio-Valera M. Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol 2017;83:1328-40. [Ref.ID 101944]
12. Cita con resumen
Anónimo. Frailty, polypharmacy and deprescribing. Drug Ther Bull 2016;54:69-72. [Ref.ID 100403]
13. Cita con resumen
14.Tiene citas relacionadas
Willett WC. Mediterranean diet and fracture risk. JAMA Intern Med 2016;176:652-3. [Ref.ID 100258]
15.Tiene citas relacionadas Cita con resumen
Haring B, Crandall CJ, Wu C, LeBlanc ES, Shikanty JM, Carbone L, Orchard T, Thomas F, Wactawaski-Wende J, Li W, Cauley JA, Wassertheil-Smoller S. Dietary patterns and fractures in postmenopausal women: results from the Women's Health Initiative. JAMA Intern Med 2016;176:645-52. [Ref.ID 100257]
16.Tiene citas relacionadas Cita con resumen
Huffman MD. The polypill: from promise to pragmatism. PLOS Medicine 2015;12:11 de agosto. [Ref.ID 99454]
17.Tiene citas relacionadas Cita con resumen
Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology 2015;22:920-30. [Ref.ID 99443]
18. Cita con resumen
Anónimo. CDC: just 30% of Americans with HIV have it under control. DIA Daily 2014:26 de noviembre. [Ref.ID 98336]
19.Tiene citas relacionadas Cita con resumen
Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Paraq V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ 2014;348:g3318. [Ref.ID 98026]
20.Tiene citas relacionadas Cita con resumen
Huffman MD. Fixed dose combinations of cardiovascular drugs. BMJ 2014;348:g3480. [Ref.ID 98023]
Seleccionar todas
 
 1 a 20 de 812 siguiente >>